Lauren Riker's most recent trade in Pacira BioSciences Inc was a trade of 5,578 Common Stock done at an average price of $26.2 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 26.21 per share. | 03 Jun 2025 | 5,578 | 59,564 (0%) | 0% | 26.2 | 146,208 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.40 per share. | 03 Jun 2025 | 3,374 | 65,142 (0%) | 0% | 26.4 | 89,074 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 30,600 | 68,516 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.33 per share. | 02 Jan 2025 | 159 | 37,916 (0%) | 0% | 18.3 | 2,914 | Common Stock |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 12 Jun 2024 | 21,360 | 42,045 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 12 Jun 2024 | 3,970 | 38,075 (0%) | 0% | 28.7 | 114,018 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 03 Jun 2024 | 1,843 | 20,685 (0%) | 0% | 30.9 | 56,930 | Common Stock | |
| Pacira BioSciences Inc | Riker Lauren | Senior Vice President, Finance | 02 Jan 2024 | 159 | 22,528 (0%) | 0% | 32 | 5,088 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 10,000 | 29,053 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 5,773 | 22,694 (0%) | 0% | 38.5 | 222,376 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 586 | 28,467 (0%) | 0% | 37.5 | 21,957 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 14 Jun 2023 | 7 | 22,687 (0%) | 0% | 39 | 273 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2023 | 616 | 19,053 (0%) | 0% | 37.9 | 23,325 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2023 | 591 | 19,669 (0%) | 0% | 39.0 | 23,044 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 14,600 | 14,600 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 5,850 | 19,852 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 06 Jun 2022 | 1,150 | 14,002 (0%) | 0% | 61.4 | 70,580 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 9,300 | 24,452 (0%) | 0% | 10.8 | 100,533 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 9,300 | 0 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 8,400 | 16,052 (0%) | 0% | 71.1 | 597,576 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 10 Mar 2022 | 900 | 15,152 (0%) | 0% | 72.0 | 64,755 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 17,652 (0%) | 0% | 10.8 | 27,025 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 9,300 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 18 Jan 2022 | 2,500 | 15,152 (0%) | 0% | 65.0 | 162,430 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 04 Jan 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Senior Vice President, Finance | 04 Jan 2022 | 2,000 | 15,152 (0%) | 0% | 0 | Common Stock | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 2,410 | 13,152 (0%) | 0% | 60.9 | 146,649 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 2,410 | 11,890 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 2,410 | 15,562 (0%) | 0% | 10.8 | 26,052 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 90 | 11,800 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 90 | 13,152 (0%) | 0% | 60.8 | 5,473 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 28 Jul 2021 | 90 | 13,242 (0%) | 0% | 10.8 | 973 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 04 Jun 2021 | 1,047 | 12,134 (0%) | 0% | 61.0 | 63,906 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 2,000 | 14,300 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 2,000 | 13,181 (0%) | 0% | 70.0 | 140,020 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 2,000 | 15,181 (0%) | 0% | 10.8 | 21,620 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 1,520 | 13,181 (0%) | 0% | 73.3 | 111,386 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 1,520 | 16,300 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 15 Mar 2021 | 1,520 | 14,701 (0%) | 0% | 10.8 | 16,431 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 13 Nov 2020 | 3,000 | 17,820 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 13 Nov 2020 | 3,000 | 13,181 (0%) | 0% | 63.8 | 191,430 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 13 Nov 2020 | 3,000 | 16,181 (0%) | 0% | 10.8 | 32,430 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 16 Sep 2020 | 3,000 | 13,181 (0%) | 0% | 60.3 | 181,020 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 16 Sep 2020 | 3,000 | 20,820 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 16 Sep 2020 | 3,000 | 16,181 (0%) | 0% | 10.8 | 32,430 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 11 Aug 2020 | 8,180 | 0 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 11 Aug 2020 | 8,180 | 20,813 (0%) | 0% | 10.3 | 84,581 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 11 Aug 2020 | 8,180 | 13,181 (0%) | 0% | 60.5 | 494,890 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 29 Jun 2020 | 6,000 | 8,180 | - | - | Stock Option (Right to Buy) | ||
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 29 Jun 2020 | 6,000 | 18,633 (0%) | 0% | 10.3 | 62,040 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 29 Jun 2020 | 2,000 | 14,633 (0%) | 0% | 49.3 | 98,680 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 29 Jun 2020 | 2,000 | 12,633 (0%) | 0% | 50.3 | 100,680 | Common Stock | |
| Pacira BioSciences Inc | Lauren Riker | Vice President, Finance | 29 Jun 2020 | 2,000 | 16,633 (0%) | 0% | 48.7 | 97,440 | Common Stock |